To confirm the direct involvement of SOX2 in oncogenic and inflammatory activities, we performed pathway analysis on SOX2 ChIP-seq data and observed a strong enrichment in pathways driving several cancer entities as well as NFkB-related inflammatory properties (IL17 signaling pathway; Fig. 2D, right panel). The gene discussed is NFKB1; the disease is cancer.